Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
54.48
+0.46 (0.85%)
At close: Apr 28, 2026, 4:00 PM EDT
55.00
+0.52 (0.95%)
After-hours: Apr 28, 2026, 4:33 PM EDT
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $364.59 million as of April 28, 2026. Its market cap has increased by 87.15% in one year.
Market Cap
364.59M
Enterprise Value
224.43M
1-Year Change
87.15%
Ranking
Category
Stock Price
$54.48
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $364.59M, an increase of 32.02%. That is a compound annual growth rate of 4.47%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Autolus Therapeutics | 383.25M |
| X4 Pharmaceuticals | 373.68M |
| Opus Genetics | 373.43M |
| Avalo Therapeutics | 371.86M |
| Silence Therapeutics | 363.70M |
| Palisade Bio | 348.24M |
| Ovid Therapeutics | 342.87M |
| DiaMedica Therapeutics | 341.08M |